Chemical Compound
3-Cyclohexene-1-methanol, ?,4-dimethyl-?-(4-methyl-3-penten-1-yl)-, (?R,1R)-rel-; 3-Cyclohexene-1-methanol, ?,4-dimethyl-?-(4-methyl-3-pentenyl)-, (R*,R*)-; 3-Cyclohexene-1-methanol, ?,4-dimethyl-?-(4-methyl-3-pentenyl)-, (?R,1R)-rel- (9CI); 5-Hepten-2-ol, 6-methyl-2-(4-methyl-3-cyclohexen-1-yl)- (6CI,7CI,8CI); rel-(?R,1R)-?,4-Dimethyl-?-(4-methyl-3-penten-1-yl)-3-cyclohexene-1-methanol; (+/-)-?-Bisabolol; Bisabolol; Camilol; Dragosantol; Dragosantol 100; Hydagen B; dl-?-Bisabolol; ?-Bisabolol
CAS Registry Number
23089-26-1
Primary record
3-Cyclohexene-1-methanol, ?,4-dimethyl-?-(4-methyl-3-penten-1-yl)-, (?R,1R)-rel-; 3-Cyclohexene-1-methanol, ?,4-dimethyl-?-(4-methyl-3-pentenyl)-, (R*,R*)-; 3-Cyclohexene-1-methanol, ?,4-dimethyl-?-(4-methyl-3-pentenyl)-, (?R,1R)-rel- (9CI); 5-Hepten-2-ol, 6-methyl-2-(4-methyl-3-cyclohexen-1-yl)- (6CI,7CI,8CI); rel-(?R,1R)-?,4-Dimethyl-?-(4-methyl-3-penten-1-yl)-3-cyclohexene-1-methanol; (+/-)-?-Bisabolol; Bisabolol; Camilol; Dragosantol; Dragosantol 100; Hydagen B; dl-?-Bisabolol; ?-Bisabolol
- 库存
- 951 克
- 纯度
- 99.5 %
- CAS
- 23089-26-1
化合物标识与属性
- CAS
- 23089-26-1
- PubChem CID
- 442343
- SMILES
- CC1=CC[C@H](CC1)[C@](C)(CCC=C(C)C)O
- Canonical SMILES
- CC(C)=CCC[C@](C)(O)[C@@H]1CC=C(C)CC1
名称与同义词
- LEVOMENOL
- (-)-alpha-Bisabolol
- alpha-Bisabolol
- Bisabolol
- Kamillosan
- Levomenolum
- Kamilosan
- alpha-(-)-Bisabolol
- 23089-26-1
- .alpha.-Bisabolol
- 1-alpha-Bisabolol
- Dragosantol
- Levomenol [INN]
- Bisbalol
- Camilol
- a-Bisabolol
- alpha-Bisabolol, L-
- Hydagen B
- Natural Bisabolol
- (-)-|A-Bisabolol
- Levomenol, INN
- L-alpha-Bisabolol
- (-)-a-Bisabolol
- l-.alpha.-Bisabolol
- Levomenol (Standard)
- (-)-?-Bisabolol
- alpha-Bisabolol (-)-form
- (?)-|A-Bisabolol
- (-)-.alpha.-Bisabolol
- Levomenolum [INN-Latin]
- UNII-24WE03BX2T
- -ALPHA-BISABOLOL
- BISABOLOL, ALPHA
- PurpleU BAOBAB FACE
- Dragosantol (>80%)
- RefChem:40862
- Bisabolol, (-)-.alpha.
- .alpha.-Bisabolol, L-
- AC1L9CMZ
- (-)- alpha -Bisabolol
- .alpha.-(-)-Bisabolol
- .alpha.-bisabolol, (-)-
- 24WE03BX2T
- BISABOLOL [VANDF]
- CCRIS 9081
- Levomenolum (INN-Latin)
- DTXSID4042094
- .alpha.-Bisabolol (-)-form
- LEVOMENOL (MART.)
- LEVOMENOL [MART.]
- (-)--BISABOLOL
- ALPHA-(-)BISABOLOL
- BISABOLOL, .ALPHA.
- LEVOMENOL (USP-RS)
- LEVOMENOL [USP-RS]
- LEVOMENOL [WHO-DD]
- BISABOLOL, (-)-alpha
- RGZSQWQPBWRIAQ-CABCVRRESA-N
- UNII-36HQN158VC
- SCHEMBL24989
- DTXCID2022094
- FEMA NO. 4666
- RACEMIC ALFA-BISABOLOL
- alpha-BISABOLOL, (-)-
- CHEBI:125
- Levomenol; (-)-a-Bisabolol
- C15H26O
- EINECS 245-423-3
- MFCD03412455
- orb1685377
- (.alpha.s,1s)-.alpha.-bisabolol
- (alphaS,1S)-alpha-BISABOLOL
- CHEMBL1096927
- HY-N6967R
- 3-CYCLOHEXENE-1-METHANOL
- (-)-(4S,8S)-alpha-Bisabolol
- (-)-alpha-Bisabolol (Levomenol)
- GLXC-20390
- HY-N6967
- ZINC1849759
- [S-(R*,R*)]-.alpha.-Bisabolol
- BISABOLA-1,12-DIEN-8-OL
- EINECS 208-205-9
- EINECS 246-973-7
- Tox21_301375
- BDBM50382730
- C15-H26-O
- CID442343
- EBC-26234
- NSC782530
- (2S)-6-methyl-2-[(1S)-4-methylcyclohex-3-en-1-yl]hept-5-en-2-ol
- Levomenol 100 microg/mL in Methanol
- DB13153
- FB75117
- LMPR0103060001
- NSC-782530
- (-)-alpha-Bisabolol, >=93% (GC)
- (-)-6-Methyl-2-(4-methyl-3-cyclohexen-1-yl)-5-hepten-2-ol
- (-)-Alpha-bisabolol(-)-alpha-bisabolol
- NCGC00255987-01
- (-)-alpha-Bisabolol, analytical standard
- DA-74979
- J38.588C
- TS-09816
- .ALPHA.-BISABOLOL (-)-FORM [MI]
- CAS-23089-26-1
- ?-Bisabolol 1000 microg/mL in Isopropanol
- 3-Cyclohexene-1-methanol, a,4-dimethyl-a-(4-methyl-3-pentenyl)-,(aS,1S)-
- CS-0028206
- NS00068750
- C09621
- G13201
- (S)-6-Methyl-2-((S)-4-methylcyclohex-3-en-1-yl)hept-5-en-2-ol
- EN300-19632355
- Q179896
- A1201883
- (-)-alpha-BISABOLOL (CONSTITUENT OF CHAMOMILE)
- 3-Cyclohexene-1-methanol, alpha,4-dimethyl-alpha-(4-methyl-3-pentenyl)-, (alphaS,1S)-
- BRD-K62751771-001-01-3
- ((-))-6-Methyl-2-(4-methyl-3-cyclohexen-1-yl)-5-hepten-2-ol
- 5-Hepten-2-ol, 6-methyl-2-(4-methyl-3-cyclohexen-1-yl)-, (-)-
- 6-Methyl-2-(4-methyl-3-cyclohexen-1-yl)-5-hepten-2-ol
- B1370-273703
- (-)-alpha-Bisabolol, primary pharmaceutical reference standard
- 515-69-5
- Levomenol, United States Pharmacopeia (USP) Reference Standard
- (-)-.ALPHA.-BISABOLOL (CONSTITUENT OF CHAMOMILE) [DSC]
- (2S)-2-[(1S)-4-Methyl-3-cyclohexenyl]-6-methyl-5-heptene-2-ol
- (S)-6-Methyl-2-[(S)-4-methyl-3-cyclohexenyl]-5-heptene-2-ol
- 3-Cyclohexene-1-methanol, .alpha.,4-dimethyl-.alpha.-(4-methyl-3-pentenyl)-, [S-(R*,R*)]-
- 3-Cyclohexene-1-methanol, alpha,4-dimethyl-alpha-(4-methyl-3-pentenyl)-, (S-(theta,theta))-
- 6-Methyl-2-(4-methyl-3-cyclohexen-1-yl)-5-hepten-2-ol, (-)-
- (?)-6-Methyl-2-(4-methyl-3-cyclohexen-1-yl)-5-hepten-2-ol,Levomenol
- 3-Cyclohexene-1-methanol, ?,4-dimethyl-?-(4-methyl-3-pentenyl)-, (R,R)-
- 5-HEPTEN-2-OL, 6-METHYL-2-(4- METHYL-3-CYCLOHEXEN-1-YL), (-)-
- 5-HEPTEN-2-OL, 6-METHYL-2-(4-METHYL-3-CYCLOHEXEN-1-YL), (-)-
- alpha,4-Dimethyl-alpha-(4-methyl-3-pentenyl)-3-cyclohexene-1-methanol
- (alpha R,1R)-rel-alpha,4-Dimethyl-alpha-(4-methyl-3-penten-1-yl)-3-cyclohexene-1-methanol
- (R*, R*)- a, 4- dimethyl- a- (4- methyl- 3- pentenyl)cyclohex- 3- ene- 1- methanol
- (R*,R*)-alpha,4-Dimethyl-alpha-(4-methyl-3-pentenyl)cyclohex-3-ene-1-methanol
- [1S,alphaS,(-)]-alpha,4-Dimethyl-alpha-(4-methyl-3-pentenyl)-3-cyclohexene-1-methanol
- [S-(R*,R*)]-.alpha.,4-Dimethyl-.alpha.-(4-methyl-3-pentenyl)cyclohex-3-ene-1-methanol
- 3-ciclohexeno-1-metanol, ?,4-dimetil-?-(4-metil-3-penten-1-il)-, (?s,1s)-
- 3-Cyclohexene-1-methanol, .alpha.,4-dimethyl-.alpha.-(4-methyl-3-pentenyl)-, (-)-
- 3-Cyclohexene-1-methanol, .alpha.,4-dimethyl-.alpha.-(4-methyl-3-pentenyl)-, (R*,R*)-
- 3-Cyclohexene-1-methanol, ?,4-dimethyl-?-(4-methyl-3-pentenyl)-, [S-(R,R)]-
- 3-Cyclohexene-1-methanol, alpha,4-dimethyl-alpha-(4-methyl-3-pentenyl)-, (.alpha.S,1S)-
- 3-Cyclohexene-1-methanol, alpha,4-dimethyl-alpha-(4-methyl-3-pentenyl)-, (S-(R*,R*))-
- alpha,4-Dimethyl-alpha-(4-methyl-3-penten-1-yl)-(alphaS,1S)-3-Cyclohexene-1-methanol
- (R*,R*) - a,4 - dimethyl - a - (4 - methyl - 3 - pentenyl)cyclohex - 3 - ene - 1 - methanol
- 245-423-3
- 3-ciclohexeno-1-metanol, Alfa,4-Dimetil-Alfa-(4-metil-3-penten-1-il)-, (Alfa R, 1R)-rel-
- 3-CYCLOHEXENE-1-METHANOL, .ALPHA.,4-DIMETHYL-.ALPHA.-(4-METHYL-3-PENTEN-1-YL)-, (.ALPHA.S,1S)-
- 3-Cyclohexene-1-methanol, .alpha.,4-dimethyl-.alpha.-(4-methyl-3-pentenyl)-, (.alpha.R,1R)-rel-
- 3-Cyclohexene-1-methanol, ?,4-dimethyl-?-(4-methyl-3-penten-1-yl)-, (?R,1R)-rel-; 3-Cyclohexene-1-methanol, ?,4-dimethyl-?-(4-methyl-3-pentenyl)-, (R*,R*)-; 3-Cyclohexene-1-methanol, ?,4-dimethyl-?-(4-methyl-3-pentenyl)-, (?R,1R)-rel- (9CI); 5-Hepten-2-ol, 6-methyl-2-(4-methyl-3-cyclohexen-1-yl)- (6CI,7CI,8CI); rel-(?R,1R)-?,4-Dimethyl-?-(4-methyl-3-penten-1-yl)-3-cyclohexene-1-methanol; (+/-)-?-Bisabolol; Bisabolol; Camilol; Dragosantol; Dragosantol 100; Hydagen B; dl-?-Bisabolol; ?-Bisabolol
- 3-Cyclohexene-1-methanol, a,4-dimethyl-a-(4-methyl-3-penten-1-yl)-, (aR,1R)-rel-; 3-Cyclohexene-1-methanol, a,4-dimethyl-a-(4-methyl-3-pentenyl)-, (R*,R*)-; 3-Cyclohexene-1-methanol, a,4-dimethyl-a-(4-methyl-3-pentenyl)-, (aR,1R)-rel- (9CI); 5-Hepten-2-ol, 6-methyl-2-(4-methyl-3-cyclohexen-1-yl)- (6CI,7CI,8CI); rel-(aR,1R)-a,4-Dimethyl-a-(4-methyl-3-penten-1-yl)-3-cyclohexene-1-methanol; (+/-)-a-Bisabolol; Bisabolol; Camilol; Dragosantol; Dragosantol 100; Hydagen B; dl-a-Bisabolol; a-Bisabolol
- 3-CYCLOHEXENE-1-METHANOL, alpha,4-DIMETHYL-alpha-(4-METHYL-3-PENTEN-1-YL)-, (alphaS,1S)-